The Specific Immune Response — 特异性免疫应答

📚 The Specific Immune Response | 特异性免疫应答

The immune system is the body’s defence network against pathogens — microorganisms that cause disease, including bacteria, viruses, fungi, and protoctists. It can be divided into two broad categories: the innate (non-specific) immune system and the adaptive (specific) immune system. While the innate system provides a rapid, generalised response — involving physical barriers like skin, chemical defences like stomach acid, and cellular responses like phagocytosis — the adaptive immune system is slower to activate but highly specific and long-lasting. For A-Level Biology, understanding the specific immune response is essential: it explains how the body recognises and remembers pathogens, how vaccines work, and what happens when the system goes wrong in autoimmune conditions.

免疫系统是人体对抗病原体（引起疾病的微生物，包括细菌、病毒、真菌和原生生物）的防御网络。它可以分为两大类：先天（非特异性）免疫系统和适应性（特异性）免疫系统。先天系统提供快速、普遍的应答——涉及皮肤等物理屏障、胃酸等化学防御以及吞噬作用等细胞反应——而适应性免疫系统激活较慢，但具有高度特异性和持久性。对于A-Level生物学，理解特异性免疫应答至关重要：它解释了人体如何识别和记忆病原体、疫苗如何发挥作用，以及当系统出错时会发生什么（如自身免疫性疾病）。

1. Antigens and Self/Non-Self Recognition | 抗原与自我/非自我识别

At the heart of the specific immune response lies the concept of antigens. An antigen is any molecule — typically a protein or glycoprotein — that the immune system can recognise as foreign and mount a response against. Antigens are found on the surface of pathogens, on cells infected by viruses, on cancer cells, and even on transplanted tissues. The immune system distinguishes between self-antigens (molecules produced by the organism’s own body, which are tolerated) and non-self antigens (foreign molecules that trigger an immune response). This self/non-self discrimination is fundamental — when it fails, autoimmune diseases such as type 1 diabetes and rheumatoid arthritis can develop.

特异性免疫应答的核心概念是抗原。抗原是任何可以被免疫系统识别为外来物并引发免疫应答的分子——通常是蛋白质或糖蛋白。抗原存在于病原体表面、病毒感染细胞上、癌细胞上，甚至移植组织上。免疫系统区分自身抗原（机体自身产生的、被耐受的分子）和非自身抗原（引发免疫应答的外来分子）。这种自我/非自我区分是根本性的——当它失效时，就会发展成1型糖尿病和类风湿关节炎等自身免疫性疾病。

Each lymphocyte — whether a B cell or a T cell — carries specific receptor proteins on its surface that are complementary to a particular antigen. A given lymphocyte can recognise only one specific antigen shape. This is the molecular basis of immune specificity: the body maintains a vast repertoire of lymphocytes, each with a unique receptor, waiting to encounter its matching antigen. When binding occurs, that lymphocyte becomes activated and undergoes rapid clonal expansion.

每个淋巴细胞——无论是B细胞还是T细胞——在其表面携带特定的受体蛋白，这些受体与特定抗原互补。一个给定的淋巴细胞只能识别一种特定的抗原形状。这是免疫特异性的分子基础：身体维持着庞大的淋巴细胞库，每个都有独特的受体，等待遇到其匹配的抗原。当结合发生时，该淋巴细胞被激活并进行快速克隆扩增。

2. Cell-Mediated Immunity: T Lymphocytes | 细胞介导免疫：T淋巴细胞

Cell-mediated immunity is driven by T lymphocytes (T cells), which mature in the thymus gland. T cells respond to antigens that have been presented on the surface of body cells — this is a crucial distinction from B cells, which can recognise free-floating antigens. T cells only “see” antigens when they are displayed on the surface of other cells by special molecules called Major Histocompatibility Complex (MHC) proteins.

细胞介导免疫由T淋巴细胞（T细胞）驱动，它们在胸腺中成熟。T细胞对被呈递在体细胞表面的抗原作出应答——这是与B细胞的关键区别，B细胞可以识别游离的抗原。T细胞只有在抗原由称为主要组织相容性复合体（MHC）蛋白的特殊分子展示在其他细胞表面时才能”看到”抗原。

There are several types of T cells, each with a distinct role. T helper cells (Th cells, CD4+) are the orchestrators of the immune response. When their T-cell receptor binds to an antigen-MHC complex on an antigen-presenting cell (such as a macrophage or dendritic cell), they become activated and release cytokines — chemical messengers that stimulate B cells to divide and produce antibodies, activate cytotoxic T cells, and attract more phagocytes to the site of infection. T cytotoxic cells (Tc cells, CD8+) are the killers: they recognise and destroy virus-infected cells and cancer cells by releasing perforin (which creates pores in the target cell membrane) and granzymes (which induce apoptosis). T memory cells persist long after the infection has cleared, enabling a faster and stronger response upon re-exposure to the same pathogen.

有几种类型的T细胞，每种都有不同的作用。T辅助细胞（Th细胞，CD4+）是免疫应答的协调者。当它们的T细胞受体与抗原呈递细胞（如巨噬细胞或树突状细胞）上的抗原-MHC复合物结合时，它们被激活并释放细胞因子——化学信使，刺激B细胞分裂并产生抗体，激活细胞毒性T细胞，并吸引更多吞噬细胞到感染部位。T细胞毒性细胞（Tc细胞，CD8+）是杀手：它们通过释放穿孔素（在靶细胞膜上形成孔洞）和颗粒酶（诱导细胞凋亡）来识别和摧毁病毒感染的细胞和癌细胞。T记忆细胞在感染清除后长期存在，使再次接触相同病原体时产生更快更强的应答。

HIV attacks T helper cells specifically, progressively depleting the CD4+ population. When the T helper cell count drops below a critical threshold, the immune system can no longer coordinate effective responses, leading to AIDS — acquired immune deficiency syndrome — where opportunistic infections become life-threatening.

HIV专门攻击T辅助细胞，逐渐消耗CD4+群体。当T辅助细胞计数降至关键阈值以下时，免疫系统无法再协调有效的应答，导致艾滋病——获得性免疫缺陷综合征——机会性感染变得危及生命。

3. Humoral Immunity: B Lymphocytes and Antibodies | 体液免疫：B淋巴细胞与抗体

Humoral immunity — so called because it involves substances dissolved in the body fluids (the “humours”) — is mediated by B lymphocytes (B cells), which mature in the bone marrow. B cells carry membrane-bound antibodies (B-cell receptors) on their surface that can bind directly to free antigens in the blood and lymph — no MHC presentation is required. When a B cell’s receptor binds to its complementary antigen, and it receives cytokine signals from activated T helper cells, the B cell becomes activated.

体液免疫——之所以这样命名，是因为它涉及溶解在体液中的物质——由在骨髓中成熟的B淋巴细胞（B细胞）介导。B细胞在其表面携带膜结合抗体（B细胞受体），可以直接与血液和淋巴中的游离抗原结合——不需要MHC呈递。当B细胞的受体与其互补抗原结合，并接收来自活化的T辅助细胞的细胞因子信号时，B细胞被激活。

Once activated, the B cell undergoes clonal selection and expansion: it divides rapidly by mitosis, producing a large clone of genetically identical cells. These differentiate into two cell types. Plasma cells are antibody factories — they produce and secrete massive quantities of soluble antibodies (up to 2,000 per second per cell) into the blood and tissue fluid. These antibodies are identical to the B-cell receptor that originally bound the antigen. Plasma cells are short-lived, typically surviving only a few days to weeks. B memory cells, like their T-cell counterparts, persist for years or even decades, providing long-term immunological memory.

一旦激活，B细胞经历克隆选择和扩增：它通过有丝分裂快速分裂，产生一大群基因相同的细胞克隆。这些细胞分化为两种类型。浆细胞是抗体工厂——它们产生并分泌大量可溶性抗体（每个细胞每秒多达2,000个）到血液和组织液中。这些抗体与最初结合抗原的B细胞受体相同。浆细胞寿命短，通常只能存活几天到几周。B记忆细胞，像它们的T细胞对应物一样，可以持续数年甚至数十年，提供长期免疫记忆。

The process of clonal selection is Darwinian at the cellular level: among the millions of B cells, each with a different receptor, the one whose receptor happens to match the invading antigen is “selected” for expansion. This single cell gives rise to an army of identical effector cells, all producing the same antibody. This explains the lag phase of the primary immune response — it takes time (typically 5-10 days) for the right clone to be identified and expanded to sufficient numbers.

克隆选择的过程在细胞水平上是达尔文式的：在数百万个B细胞中，每个都有不同的受体，那些受体恰好匹配入侵抗原的细胞被”选择”进行扩增。这个单一细胞产生一支相同效应细胞的大军，都产生相同的抗体。这解释了初次免疫应答的滞后阶段——识别正确的克隆并将其扩增到足够数量需要时间（通常为5-10天）。

4. Antibody Structure and Function | 抗体的结构与功能

Antibodies (immunoglobulins) are Y-shaped glycoproteins with a remarkably consistent structure. Each antibody molecule consists of four polypeptide chains: two identical heavy chains and two identical light chains, held together by disulfide bonds. The molecule can be divided into two functional regions. The variable region (at the tips of the Y arms) is unique to each antibody and contains the antigen-binding site — a precisely shaped pocket that is complementary to a specific antigen. The variability in this region is generated by V(D)J recombination during B-cell development, allowing the immune system to produce antibodies against an estimated 10^11 different antigen shapes. The constant region (the stem of the Y) is the same for all antibodies of a given class and determines the antibody’s effector function — how it interacts with other immune components.

抗体（免疫球蛋白）是Y形的糖蛋白，结构非常一致。每个抗体分子由四条多肽链组成：两条相同的重链和两条相同的轻链，通过二硫键连接。分子可分为两个功能区域。可变区（Y臂的尖端）对每个抗体是独特的，包含抗原结合位点——一个精确定形的口袋，与特定抗原互补。该区域的变异由B细胞发育过程中的V(D)J重组产生，使免疫系统能够产生针对估计10^11种不同抗原形状的抗体。恒定区（Y的茎部）对于给定类别的所有抗体是相同的，决定抗体的效应功能——它如何与其他免疫成分相互作用。

Antibodies do not destroy pathogens directly. Instead, they neutralise threats through several mechanisms. Neutralisation: antibodies bind to toxins or viral surface proteins, physically blocking them from interacting with host cells. Agglutination: antibodies cross-link multiple pathogens into clumps, making them easier targets for phagocytes. Opsonisation: the constant region acts as a flag that phagocytes recognise, enhancing engulfment. Complement activation: antibody-antigen complexes trigger the complement cascade, a series of plasma proteins that punch holes in bacterial cell membranes.

抗体不直接摧毁病原体。相反，它们通过几种机制中和威胁。中和作用：抗体与毒素或病毒表面蛋白结合，物理性地阻止它们与宿主细胞相互作用。凝集作用：抗体将多个病原体交联成团块，使它们更容易被吞噬细胞靶向。调理作用：恒定区充当吞噬细胞识别的标记，增强吞噬作用。补体激活：抗体-抗原复合物触发补体级联反应——一系列在细菌细胞膜上穿孔的血浆蛋白。

5. Primary vs Secondary Immune Response | 初次与再次免疫应答

One of the most important concepts in immunology — and a classic A-Level exam question — is the difference between primary and secondary immune responses. The primary response occurs when the immune system encounters a pathogen for the first time. It is characterised by a lag phase of 5-10 days while the appropriate B and T cell clones are selected and expanded. During this period, the individual may develop symptoms of the disease. Antibody concentration rises relatively slowly, peaks at a moderate level, and then declines.

免疫学中最重要的概念之一——也是经典的A-Level考试题目——是初次和再次免疫应答之间的区别。初次应答发生在免疫系统首次遇到病原体时。其特征是在选择和扩增适当的B和T细胞克隆时有5-10天的滞后阶段。在此期间，个体可能出现疾病症状。抗体浓度上升相对缓慢，在中等水平达到峰值，然后下降。

The secondary response occurs upon re-exposure to the same pathogen. Memory B and T cells, generated during the primary response, are already present in the body. They recognise the antigen immediately and mount a response that is faster (hours rather than days), stronger (much higher antibody concentration), and more prolonged. The individual typically does not develop symptoms — they may not even realise they were re-infected. This is the immunological basis of vaccination.

再次应答发生在再次接触相同病原体时。在初次应答中产生的记忆B细胞和T细胞已经存在于体内。它们立即识别抗原并发起更快（数小时而非数天）、更强（抗体浓度高得多）和更持久的应答。个体通常不会出现症状——甚至可能没有意识到自己被再次感染。这是疫苗接种的免疫学基础。

6. Vaccination and Herd Immunity | 疫苗接种与群体免疫

Vaccination exploits the principle of immunological memory. A vaccine contains antigens derived from a pathogen — these may be inactivated (killed) whole organisms, attenuated (weakened) live organisms, subunit antigens (purified proteins), or, most recently, mRNA encoding a viral protein. The antigens are present in a form that cannot cause disease but can still stimulate a primary immune response, generating memory cells without the individual having to suffer through the actual illness. Booster vaccinations are often given to strengthen and prolong immunological memory by triggering repeated secondary responses.

疫苗接种利用免疫记忆的原理。疫苗含有源自病原体的抗原——这些可能是灭活（杀死的）全生物体、减毒（削弱的）活生物体、亚单位抗原（纯化蛋白），或最新的编码病毒蛋白的mRNA。抗原以不能引起疾病但仍能刺激初次免疫应答的形式存在，产生记忆细胞而无需个体经历实际疾病。通常给予加强针疫苗以通过触发重复的再次应答来加强和延长免疫记忆。

Herd immunity occurs when a sufficiently high proportion of a population is immune to a pathogen — either through vaccination or prior infection — that the pathogen cannot spread effectively. The threshold for herd immunity depends on the pathogen’s basic reproduction number (R₀). For measles, with an R₀ of 12-18, roughly 95% of the population must be immune. For COVID-19 (original strain, R₀ ≈ 2-3), the threshold was approximately 60-70%. Herd immunity protects vulnerable individuals who cannot be vaccinated, such as newborns, the immunocompromised, and those with severe allergies to vaccine components.

群体免疫发生在足够高比例的人群对病原体具有免疫力时——无论是通过疫苗接种还是先前感染——使病原体无法有效传播。群体免疫的阈值取决于病原体的基本传染数（R₀）。对于麻疹，R₀为12-18，大约95%的人口需要免疫。对于COVID-19（原始毒株，R₀≈2-3），阈值约为60-70%。群体免疫保护无法接种疫苗的脆弱个体，如新生儿、免疫功能低下者以及对疫苗成分严重过敏的人。

7. When the System Fails: Autoimmune Disease | 当系统失灵：自身免疫性疾病

Autoimmune diseases arise when the immune system loses the ability to distinguish self from non-self and mounts an immune response against the body’s own tissues. Normally, lymphocytes that react against self-antigens are eliminated during development — a process called central tolerance in the thymus (for T cells) and bone marrow (for B cells). Peripheral tolerance mechanisms provide additional safeguards in the circulation. However, when these tolerance mechanisms break down, autoimmune disease can result.

自身免疫性疾病发生在免疫系统失去区分自我和非自我的能力并对身体自身组织发起免疫应答时。正常情况下，对自身抗原有反应的淋巴细胞在发育过程中被清除——这一过程称为胸腺（T细胞）和骨髓（B细胞）中的中枢耐受。外周耐受机制在循环中提供额外的保护。然而，当这些耐受机制崩溃时，就可能导致自身免疫性疾病。

Examples covered in A-Level specifications include type 1 diabetes, where T cells destroy the insulin-producing beta cells of the pancreas, and rheumatoid arthritis, where antibodies attack the synovial membrane of joints. Multiple sclerosis involves T-cell-mediated destruction of the myelin sheath surrounding neurons. The causes are multifactorial — involving genetic predisposition (certain HLA alleles), environmental triggers (viral infections), and sometimes molecular mimicry, where a pathogen’s antigens happen to resemble self-antigens closely enough to confuse the immune system.

A-Level考试大纲中涵盖的例子包括1型糖尿病，T细胞摧毁胰腺中产生胰岛素的β细胞；以及类风湿关节炎，抗体攻击关节的滑膜。多发性硬化症涉及T细胞介导的神经元周围髓鞘的破坏。病因是多因素的——涉及遗传易感性（某些HLA等位基因）、环境触发因素（病毒感染），有时还有分子模拟——病原体的抗原恰好与自身抗原有足够的相似性以混淆免疫系统。

8. Monoclonal Antibodies in Medicine | 医学中的单克隆抗体

A direct application of the specific immune response is the production and use of monoclonal antibodies. These are antibodies produced from a single clone of B cells (specifically, hybridoma cells — fusions of B cells with myeloma cancer cells to create immortal antibody-producing cell lines). Because all the antibodies come from a single clone, they are identical and recognise the same epitope on the same antigen. Monoclonal antibodies have revolutionised medicine: they are used in pregnancy tests (anti-hCG antibodies), cancer treatment (e.g., Herceptin/trastuzumab targeting HER2 receptors on breast cancer cells), diagnosis of disease (ELISA tests), and targeted drug delivery, where a toxic drug is attached to an antibody that specifically seeks out cancer cells.

特异性免疫应答的一个直接应用是单克隆抗体的生产和使用。这些是由单一B细胞克隆产生的抗体（具体来说，是杂交瘤细胞——B细胞与骨髓瘤癌细胞融合以创建永生的抗体产生细胞系）。因为所有抗体来自单一克隆，它们是相同的并识别同一抗原上的同一表位。单克隆抗体已经彻底改变了医学：它们用于妊娠测试（抗hCG抗体）、癌症治疗（例如赫赛汀/曲妥珠单抗靶向乳腺癌细胞上的HER2受体）、疾病诊断（ELISA测试）以及靶向药物递送——将毒性药物附着在专门寻找癌细胞的抗体上。

Component / 组成部分	Role / 作用	Key Detail / 关键细节
Antigen / 抗原	Triggers immune response / 触发免疫应答	Usually protein/glycoprotein on pathogen surface / 通常是病原体表面的蛋白/糖蛋白
T Helper Cell (CD4+)	Orchestrator: releases cytokines; activates B cells and Tc cells	Target of HIV / HIV的攻击目标
T Cytotoxic Cell (CD8+)	Killer: destroys infected cells via perforin and granzymes	Recognises antigen on MHC Class I / 识别MHC I类上的抗原
B Cell / B细胞	Humoral response: produces antibodies / 体液应答：产生抗体	Matures in bone marrow / 在骨髓中成熟
Plasma Cell / 浆细胞	Antibody factory (~2000/sec) / 抗体工厂（~2000/秒）	Short-lived (days to weeks) / 寿命短（数天至数周）
Memory Cell / 记忆细胞	Long-term immunity; enables rapid secondary response	Persists for years/decades / 持续数年至数十年
Antibody / 抗体	Neutralises, agglutinates, opsonises, activates complement	Y-shaped; variable + constant regions / Y形；可变区+恒定区
MHC / 主要组织相容性复合体	Presents antigens to T cells / 向T细胞呈递抗原	Class I (all nucleated cells); Class II (APCs only)